<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03963310</url>
  </required_header>
  <id_info>
    <org_study_id>RDS_2019_8</org_study_id>
    <nct_id>NCT03963310</nct_id>
  </id_info>
  <brief_title>Optical Coherence Tomography and Optic Neuritis Not Related to Multiple Sclerosis</brief_title>
  <acronym>OCTON2</acronym>
  <official_title>Evaluation and Follow-up of Optic Neuritis Not Related to Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The visual prognosis of optic neuritis not related to multiple sclerosis is unknown, both in
      terms of functional recovery and evolution.

      This prospective cohort study aim to assess the ophthalmological evolution of patients
      presenting an episode of optic neuritis (NO) not related to a multiple sclerosis or to a
      clinically isolated syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">April 2020</start_date>
  <completion_date type="Anticipated">May 2024</completion_date>
  <primary_completion_date type="Anticipated">May 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity (ETDRS scale)</measure>
    <time_frame>1 year</time_frame>
    <description>Evolution over 1 year of the ophthalmological parameters of patients treated for an episode of optic neuritis not related to multiple sclerosis or a clinically isolated syndrome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thickness of the layers of the retina with Optical Coherent Tomography(OCT),</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Standard Humphrey Visual Field Test</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Optic Neuritis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients seen at the Adolphe de Rothschild Foundation for the first onset of an optic
        neuritis not related to multiple sclerosis and clinically isolated syndrome
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  First onset of an optic neuritis lasting for less than 1 month

          -  With a brain MRI that does not meet the MS criteria

        Exclusion Criteria:

          -  Contra-indication to MRI

          -  Pregnant or lactating woman

          -  History of known ipsilateral optic neuritis

          -  Ophthalmologic comorbidity in the ipsilateral eye that may interfere with the
             interpretation of the examinations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Romain DESCHAMPS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation A. de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurence SALOMON, MD PhD</last_name>
    <phone>+33 1 48 03 64 31</phone>
    <email>lsalomon@for.paris</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Am√©lie YAVCHITZ, MD</last_name>
    <phone>+33 1 48 03 64 54</phone>
    <email>ayavchitz@for.paris</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fondation A. de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Romain DESCHAMPS, MD</last_name>
      <email>rdeschamps@for.paris</email>
    </contact>
    <investigator>
      <last_name>Romain DESCHAMPS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>May 20, 2019</study_first_submitted>
  <study_first_submitted_qc>May 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 24, 2019</study_first_posted>
  <last_update_submitted>February 25, 2020</last_update_submitted>
  <last_update_submitted_qc>February 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Neuritis</mesh_term>
    <mesh_term>Optic Neuritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

